Arnon Nagler, MD, MSc, Sheba Medical Center, Tel-Aviv, Israel, provides an overview of how alternative donors provide comparable results to matched unrelated donors in patients with acute lymphoblastic leukemia (ALL) undergoing autologous stem cell transplant (ASCT) in second complete remission. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).